NinePointTwo Capital’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,088
Closed -$290K 201
2022
Q3
$290K Buy
+3,088
New +$440K 0.12% 110

Other funds holding CDLX

NinePointTwo Capital's CDLX Position: Q4 2022 in Review

NinePointTwo Capital sold out of Cardlytics (CDLX) in Q4 2022, closing a stake of 3,088 shares — an estimated $290K sold.

NinePointTwo Capital first reported a position in CDLX in Q3 2022 and held it in 1 quarter. The position peaked at $290K in Q3 2022. 121 funds tracked by Wall St. Rank hold CDLX as of Q4 2022.

  • NinePointTwo Capital reported no remaining Cardlytics position as of Q4 2022 after selling out during the quarter.
  • NinePointTwo Capital sold 3,088 Cardlytics shares in Q4 2022, an estimated $290K.
  • NinePointTwo Capital first reported a position in Cardlytics in Q3 2022 and held it in 1 quarter.
  • NinePointTwo Capital's Cardlytics position peaked at $290K in Q3 2022.
  • 121 funds tracked by Wall St. Rank held Cardlytics as of Q4 2022.

Based on NinePointTwo Capital's 13F filing for Q4 2022, filed 14 Feb 2023.